Clinical Trials Sponsored by Institut de Recherches Cliniques de Montreal

Total 1806 results

Institut de Recherches Cliniques de Montreal
Université de Montréal

Withdrawn

Vitamin K Supplementation to Reduce Deficiencies in Adults With Cystic Fibrosis (VITK-FK)

Cystic Fibrosis

Canada
Institut de Recherches Cliniques de Montreal

Recruiting

Restoration of Hypoglycemia Awareness With Home-based High Intensity Interval Training (FEEL-HIIT)

Type 1 Diabetes | Hypoglycemia Unawareness

Canada
Institut de Recherches Cliniques de Montreal

Recruiting

Registry of Patients Living With Type 1 Diabetes

Type 1 Diabetes Mellitus

Canada
Institut de Recherches Cliniques de Montreal

Completed

Comparison of FiAsp and Aspart During Postprandial Exercise in Adults With Type 1 Diabetes

Type 1 Diabetes Mellitus

Canada
Institut de Recherches Cliniques de Montreal

Active, not recruiting

Electrocardiographic Modifications and Spontaneous Hypoglycemic Episodes in Type 1 Diabetes

Type 1 Diabetes Mellitus

Canada
Institut de Recherches Cliniques de Montreal

Completed

Assessment of the Efficacy of the Artificial Pancreas Combined With a Qualitative Meal Size Estimation to Control Postprandial Glucose Levels

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Effect of Low-Fat Compared to Low-Carbohydrate Diet in Subjects With Multifactorial Chylomicronemia (MCMdiet)

Multifactorial Chylomicronemia (MCM)

Canada
Institut de Recherches Cliniques de Montreal

Completed

Treatment of Hypoglycemia in Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Individualized Carbohydrate Intake Strategy to Improve Blood Glucose Control

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Impact of a Nutritional Intervention on Type1 Diabetes Adult With Metabolic Syndrome (MEDIT)

Metabolic Syndrome | Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Kinetics of YKL-40 Protein in Serum of Cystic Fibrosis Patients (Kin_YKL_CF)

Cystic Fibrosis

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Comparison of the Efficacy of Rapid-acting Aspart and Faster Acting Aspart Within the Context of Single-hormone Closed-loop Strategy at Regulating Postprandial Glucose Levels

Type 1 Diabetes Mellitus
Institut de Recherches Cliniques de Montreal

Completed

Insulin-based Strategies to Prevent Hypoglycemia During Exercise

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Terminated

Evaluating the True Magnitude of HYPOglycemic Events After THE Initiation of Sulfonylurea

Type 2 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Type 1 Diabètes Adults With Hypoglycemia Unawareness and Documented Nocturnal Hypoglycemia

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Postprandial Glucose Levels in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 60 Hours in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Not yet recruiting

Low cArbohydraTe dIeT and aUtomated Insulin Delivery System for Type 1 DiabetEs (LATITUDE)

Type 1 Diabetes
Institut de Recherches Cliniques de Montreal

Completed

Prevention of Mild-to-moderate Hypoglycemia in Type 1 Diabetes (REVERSIBLE)

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis (SNACK_CF)

Cystic Fibrosis

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 15 Weeks in Adolescents and Adults With Type 1 Diabetes

Type 1 Diabetes
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Postprandial Glucose Levels After Meals With Different Macronutrients Content in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation - Part 2

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Safety of Overestimation of a Meal Insulin Bolus in the Context of Dual-hormone Closed-loop Operation

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Exercise Program Combined or Not With Nutritional intErvention in Adults With tyPe 2 Diabetes (PEP-2)

Obesity | Overweight | Type 2 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Terminated

Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes

Hypertension | Type 2 Diabetes | Albuminuria

Canada
Institut de Recherches Cliniques de Montreal

Recruiting

Glycemic Variations During the Menstrual Cycle in Women With Type 1 Diabetes (GLYMETY)

Type1diabetes

Canada
Institut de Recherches Cliniques de Montreal

Active, not recruiting

Adipose Tissue Pre and Post Bariatric Surgery (ETAPP)

Obesity

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 12 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Carbohydrate-based Strategies to Prevent Exercise-induced Hypoglycemia

Type 1 Diabetes Mellitus

Canada
Institut de Recherches Cliniques de Montreal

Completed

Closed-loop Control of Glucose Levels (Artificial Pancreas) During Postprandial Exercise in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Comparison of Blood Pressure Measurement With an Omron HEM-907 Device in a Clinical Setting and a Research Setting (OMRONHEM-907)

Hypertension

Canada
Institut de Recherches Cliniques de Montreal

Withdrawn

Closed-loop Control of Glucose Levels (Artificial Pancreas) for 5 Days in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal

Completed

Effects of an Exercise Program Among CF Patients With Dysglycemia (FKEX)

Cystic Fibrosis | Cystic Fibrosis Related Diabetes

Canada
Montreal Heart Institute
Institut de Recherches Cliniques de Montreal

Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes II (APPEASEDII)

Diabetes Mellitus, Type 2 | Type 2 Diabetes | Platelet Aggregation | Aspirin | Platelet Aggregation Inhibitors

Canada
Montreal Heart Institute
Institut de Recherches Cliniques de Montreal

Recruiting

Assessing Pharmacokinetics and Pharmacodynamics of Daily Enteric-coated Aspirin in Patients With StablE Diabetes (APPEASED)

Diabetes Mellitus, Type 2

Canada
Institut de Recherches Cliniques de Montreal
Centre de Recherche du Centre Hospitalier de l'Université de Montréal

Withdrawn

Efficacy of Small Subcutaneous Glucagon Dose to Treat Hypoglycemia in Adults With Type 1 Diabetes

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal
Vertex Pharmaceuticals Incorporated; Université de Montréal

Completed

Simplification of CF-related Diabetes Screening at Home (AtHome)

Cystic Fibrosis | Cystic Fibrosis-related Diabetes

Canada
McGill University
Institut de Recherches Cliniques de Montreal

Active, not recruiting

The SUPPORT-Pro Online Platform for Healthcare Professionals Treating Individuals Living With T1D (SUPPORT-Pro)

Educational Activities

Canada
Institut de Recherches Cliniques de Montreal
McGill University

Withdrawn

Carbohydrates Under Target for Type 1 Diabetes Management

Type 1 Diabetes

Canada
Université de Sherbrooke
Institut de Recherches Cliniques de Montreal

Recruiting

Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency (AGL12)

Lipoprotein Lipase Deficiency

Canada
Institut de Recherches Cliniques de Montreal
Université de Montréal; Canadian Cystic Fibrosis Foundation

Completed

The Effect of Soluble Fiber to Reduce Post-prandial Glycemic Excursion in Adults With Cystic Fibrosis (SOFI)

Cystic Fibrosis | Cystic Fibrosis-related Diabetes

Canada
Institut de Recherches Cliniques de Montreal
Ottawa Hospital Research Institute

Completed

Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.

Hypertension

Canada
Centre hospitalier de l'Université de Montréal...
Institut de Recherches Cliniques de Montreal; Laval University

Not yet recruiting

Glycemic Control and Osteohealth in Adults Living With Type 1 Diabetes (GLYCO-OSTEO)

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal
University of Alberta

Recruiting

Safety and Effectiveness of Automated Insulin Delivery (AID) Systems in Physically Active Adults With Type 1 Diabetes (AIDE-1)

Type 1 Diabetes

Canada
Institut de Recherches Cliniques de Montreal
University of Alberta

Recruiting

Blood Glucose Target Before and During Exercise in Adults With Type 1 Diabetes Using an Artificial Pancreas (GUARDIA)

Type 1 Diabetes

Canada
Emilia Falcone, MD

Recruiting

Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic (IPCO)

Covid19

Canada
Centre hospitalier de l'Université de Montréal...
Fondation Pour La Recherche en Chirurgie Thoracique De Montreal; Centre de... and other collaborators

Recruiting

Use of Ex Vivo Lung Perfusion (EVLP) in Reconditioning Marginal Donor Lungs for Transplantation (EVLP-CHUM)

Lung Transplant

Canada
Ciusss de L'Est de l'Île de Montréal
Juvenile Diabetes Research Foundation; Institut de Recherches Cliniques de...

Completed

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) and Exocrine Pancreatic Dysfunction in Type 1 Diabetes

Type 1 Diabetes | Exocrine Pancreatic Insufficiency

Canada
Institut de Recherches Cliniques de Montreal
Montreal Children's Hospital of the MUHC

Completed

Closed-loop Control of Overnight Glucose Levels (Artificial Pancreas) in Children With Type 1 Diabetes in a Diabetes Camp

Type 1 Diabetes

Canada

Clinical Trials Sponsored by Institut de Recherches Cliniques de Montreal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Trinidad & Tobago

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations